These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21129131)

  • 1. Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.
    Martinez AD; Dimova R; Marks KM; Beeder AB; Zeremski M; Kreek MJ; Talal AH
    J Viral Hepat; 2012 Jan; 19(1):47-54. PubMed ID: 21129131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication.
    Bruce RD; Eiserman J; Acosta A; Gote C; Lim JK; Altice FL
    Am J Drug Alcohol Abuse; 2012 May; 38(3):206-12. PubMed ID: 22242700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy.
    Taylor LE; Bowman SE; Chapman S; Zaller N; Stein MD; Cioe PA; Maynard MA; McGovern BH
    Drug Alcohol Depend; 2011 Jul; 116(1-3):233-7. PubMed ID: 21177046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
    Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
    Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone.
    Talal AH; Andrews P; Mcleod A; Chen Y; Sylvester C; Markatou M; Brown LS
    Clin Infect Dis; 2019 Jul; 69(2):323-331. PubMed ID: 30329042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
    Grebely J; Petoumenos K; Matthews GV; Haber P; Marks P; Lloyd AR; Kaldor JM; Dore GJ; Hellard M;
    Drug Alcohol Depend; 2010 Mar; 107(2-3):244-9. PubMed ID: 19926405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance.
    Mauss S; Berger F; Goelz J; Jacob B; Schmutz G
    Hepatology; 2004 Jul; 40(1):120-4. PubMed ID: 15239094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
    Mira JA; García-Rey S; Rivero A; de los Santos-Gil I; López-Cortés LF; Girón-González JA; Téllez F; Márquez M; Merino D; Ríos-Villegas MJ; Macías J; Rivero-Juárez A; Pineda JA
    Clin Infect Dis; 2012 Dec; 55(12):1719-26. PubMed ID: 22955435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).
    Sherman KE; Andersen JW; Butt AA; Umbleja T; Alston B; Koziel MJ; Peters MG; Sulkowski M; Goodman ZD; Chung RT;
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):597-605. PubMed ID: 20921898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study.
    Midgard H; Bramness JG; Skurtveit S; Haukeland JW; Dalgard O
    PLoS One; 2016; 11(11):e0166451. PubMed ID: 27846264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus guidelines for the management of hepatitis C infection.
    Consensus Guidelines Committee for the Management of Hepatitis C Infection
    Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load.
    Neukam K; Camacho A; Caruz A; Rallón N; Torres-Cornejo A; Rockstroh JK; Macías J; Rivero A; Benito JM; López-Cortés LF; Nattermann J; Gómez-Mateos J; Soriano V; Pineda JA
    J Hepatol; 2012 Apr; 56(4):788-94. PubMed ID: 22173157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for treating HCV hepatitis in patients receiving methadone maintenance therapy.
    Malnick S; Sheidvasser V; Basevitz A; Levit S
    Isr J Psychiatry Relat Sci; 2014; 51(4):303-5. PubMed ID: 25841229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.
    Yamada G; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
    Clin Drug Investig; 2008; 28(1):9-16. PubMed ID: 18081356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.
    Nordstrom EM; Keniston A; Baouchi F; Martinez-Camacho A
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):10-16. PubMed ID: 27755117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit.
    Vafiadis I; Trilianos P; Vlachogiannakos J; Karagiorga M; Hatziliami A; Voskaridou E; Ladas SD
    Ann Hepatol; 2013; 12(4):532-8. PubMed ID: 23813130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.